美通社/ -- 泰利福公司（NYSE: TFX），全球领先的医疗技术公司，今日宣布其旗下Rüsch™ EZ-Blocker™ 一次性使用双侧支气管堵塞器已成功通过中国国家药品监督管理局（NMPA）的严格审评审批，并正式取得医疗器械注册证（注册证编号：国械注进20252080316）。这不仅是泰利福中国产品组合的一次重要升级优化，更为公司在华业务的增长注入强劲动力。

泰利福Rüsch™ EZ-Blocker™一次性使用双侧支气管堵塞器

泰利福中国始终致力于为全球医疗市场提供创新的医疗解决方案，此次 Rüsch™ EZ-Blocker™一次性使用双侧支气管堵塞器在华获批，是泰利福深耕中国市场、满足中国患者医疗需求的又一重要举措。未来，泰利福将继续优化其在中国的产品组合，为推动中国医疗健康事业的发展贡献更多力量。

About Teleflex Incorporated

As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people's lives. Through our vision to become the most trusted partner in the world of healthcare, we offer a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. We believe that the potential of great people, purpose driven innovation, and world-class products can shape the future direction of healthcare.

Teleflex is the home of Arrow™, Barrigel™, Deknatel™, LMA™, Pilling™, QuikClot™, Rüsch™, UroLift™ and Weck™ – trusted brands united by a common sense of purpose.

At Teleflex, we are empowering the future of healthcare.  

Forward-Looking Statements

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.

Teleflex, the Teleflex logo are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries.

© 2025 Teleflex Incorporated. All rights reserved. MCC-2025-0101

消息来源 : Teleflex